Business Context and Reporting Period
Company: NeuroOne Medical Technologies Corp (NMTC)
Filing Type: Form 8-K (Current Report)
Date of Report: February 25, 2026
Reporting Period: Event-based report regarding the scheduling of the 2026 Annual Meeting of Stockholders.
Key Financial Metrics
This filing does not contain financial performance data. No revenue, profit, cash flow, margins, debt, or liquidity metrics are reported in this document.
Material Changes
The filing announces a material change in the scheduling of the Company's annual shareholder meeting:
- 2026 Annual Meeting Date: Set for April 3, 2026.
- Reason for Change: The new date is more than 30 calendar days from the anniversary of the 2025 annual meeting.
- Proposal Deadline: Stockholder proposals under Rule 14a-8 must be received by March 4, 2026, to be included in the proxy materials.
Guidance, Outlook, and Risks
Management Commentary: The Board of Directors has established the meeting date. Additional details regarding the exact time, location, and matters to be voted on will be published in the upcoming proxy statement.
Risks and Contingencies: No specific risks, contingencies, or unusual items are disclosed in this filing.
Guidance: No financial guidance or operational outlook is provided.
Investor Verification Checklist
- Verify the final time and location of the 2026 Annual Meeting once the proxy statement is released.
- Confirm the specific matters to be voted on by stockholders in the upcoming proxy materials.
- Note the March 4, 2026 deadline for submitting Rule 14a-8 stockholder proposals.